XML 12 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Product Revenue, net $ 390   $ 390  
Costs and expenses:        
Cost of sales (20)   (20)  
Amortization of intangible asset (349)   (1,036) $ 0
Research and development (1,261) $ (3,107) (2,852) (9,159)
Selling, general and administrative (6,491) (1,780) (13,452) (5,867)
Total operating expenses (8,121) (4,887) (17,360) (15,026)
Operating loss (7,731) (4,887) (16,970) (15,026)
Interest expense, net (441) (590) (1,291) (1,648)
Adjustments to fair value of derivatives (673) (433) (1,807) (1,226)
Other expense, net (2) (48) (60) (77)
Total other expense (1,116) (1,071) (3,158) (2,951)
Loss before income taxes (8,847) (5,958) (20,128) (17,977)
Income tax expense (132) (136) (251) (215)
Net loss $ (8,979) $ (6,094) $ (20,379) $ (18,192)
Net loss per share - basic $ (0.2) $ (0.3) $ (0.51) $ (1.05)
Net loss per share - diluted $ (0.2) $ (0.3) $ (0.51) $ (1.05)
Weighted average ordinary shares outstanding - basic 45,801,927 20,044,270 39,975,269 17,352,918
Weighted average ordinary shares outstanding - diluted 45,801,927 20,044,270 39,975,269 17,352,918
Other comprehensive income:        
Net loss $ (8,979) $ (6,094) $ (20,379) $ (18,192)
Unrealized loss on marketable securities 0 3 0 1
Comprehensive loss $ (8,979) $ (6,091) $ (20,379) $ (18,191)